![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 11, 9887-9894, March 18, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||

From the Department of Medicine and Marion Bessin Liver Research Center, Albert Einstein College of Medicine, Bronx, New York 10461
Insulin resistance and increased cytochrome P450 2E1 (CYP2E1) expression are both associated with and mechanistically implicated in the development of nonalcoholic fatty liver disease. Although currently viewed as distinct factors, insulin resistance and CYP2E1 expression may be interrelated through the ability of CYP2E1-induced oxidant stress to impair hepatic insulin signaling. To test this possibility, the effects of in vitro and in vivo CYP2E1 overexpression on hepatocyte insulin signaling were examined. CYP2E1 overexpression in a hepatocyte cell line decreased tyrosine phosphorylation of insulin receptor substrate (IRS)-1 and IRS-2 in response to insulin. CYP2E1 overexpression was also associated with increased inhibitory serine 307 and 636/639 IRS-1 phosphorylation. In parallel, the effects of insulin on Akt activation, glycogen synthase kinase 3, and FoxO1a phosphorylation, and glucose secretion were all significantly decreased in CYP2E1 overexpressing cells. This inhibition of insulin signaling by CYP2E1 overexpression was partially c-Jun N-terminal kinase dependent. In the methionine- and choline-deficient diet mouse model of steatohepatitis with CYP2E1 overexpression, insulin-induced IRS-1, IRS-2, and Akt phosphorylation were similarly decreased. These findings indicate that increased hepatocyte CYP2E1 expression and the presence of steatohepatitis result in the down-regulation of insulin signaling, potentially contributing to the insulin resistance associated with nonalcoholic fatty liver disease.
Received for publication, September 8, 2004 , and in revised form, November 30, 2004.
* This work was supported by National Institutes of Health Grants DK61498 and DK41296. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Marion Bessin Liver Research Center, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10461. Tel.: 718-430-4255; Fax: 718-430-8975; E-mail: czaja{at}aecom.yu.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. E. Rinella, M. S. Elias, R. R. Smolak, T. Fu, J. Borensztajn, and R. M. Green Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet J. Lipid Res., May 1, 2008; 49(5): 1068 - 1076. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, R. Singh, A. C. Massey, S. S. Kane, S. Kaushik, T. Grant, Y. Xiang, A. M. Cuervo, and M. J. Czaja Loss of Macroautophagy Promotes or Prevents Fibroblast Apoptosis Depending on the Death Stimulus J. Biol. Chem., February 22, 2008; 283(8): 4766 - 4777. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Baumgardner, K. Shankar, L. Hennings, T. M. Badger, and M. J. J. Ronis A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G27 - G38. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kohli, X. Pan, P. Malladi, M. S. Wainwright, and P. F. Whitington Mitochondrial Reactive Oxygen Species Signal Hepatocyte Steatosis by Regulating the Phosphatidylinositol 3-Kinase Cell Survival Pathway J. Biol. Chem., July 20, 2007; 282(29): 21327 - 21336. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Nobili, M. Manco, P. Ciampalini, V. Diciommo, R. Devito, F. Piemonte, D. Comparcola, R. Guidi, and M. Marcellini Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur. J. Endocrinol., November 1, 2006; 155(5): 735 - 743. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Svegliati-Baroni, C. Candelaresi, S. Saccomanno, G. Ferretti, T. Bachetti, M. Marzioni, S. De Minicis, L. Nobili, R. Salzano, A. Omenetti, et al. A Model of Insulin Resistance and Nonalcoholic Steatohepatitis in Rats: Role of Peroxisome Proliferator-Activated Receptor-{alpha} and n-3 Polyunsaturated Fatty Acid Treatment on Liver Injury Am. J. Pathol., September 1, 2006; 169(3): 846 - 860. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Caro and A. I. Cederbaum Role of Phosphatidylinositol 3-Kinase/AKT as a Survival Pathway against CYP2E1-Dependent Toxicity J. Pharmacol. Exp. Ther., July 1, 2006; 318(1): 360 - 372. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Raubenheimer, M. J. Nyirenda, and B. R. Walker A Choline-Deficient Diet Exacerbates Fatty Liver but Attenuates Insulin Resistance and Glucose Intolerance in Mice Fed a High-Fat Diet. Diabetes, July 1, 2006; 55(7): 2015 - 2020. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |